Clinical Trials in North Carolina

Showing 17141-17160 of 20,428 trials

Multiple Dose Study Of PF-05231023 In Adult Subjects Who Have Poor Lipid Control With And Without Type 2 Diabetes Mellitus

NCT01673178

This is a trial in obese subjects who have poor lipid control with and without Type 2 diabetes mellitus to study the safety, tolerability and pharmacokinetics of multiple doses of PF-05231023

Diabetes Melliuts, Type 2

Pfizer107 participantsStarted Oct 2012

Anaheim, California, United States • Chula Vista, California, United States • Walnut Creek, California, United States +14 more locations

COMPLETEDPhase 325 miles

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

NCT01427283

The primary objective is to assess the efficacy of oxycodone/naloxone controlled-release tablets (OXN) for the management of opioid-induced constipation (OIC) compared with oxycodone controlled-release tablets (OXY) in subjects with moderate to severe low back pain and opioid-induced constipation who require around-the-clock opioid therapy.

Low Back Pain

Purdue Pharma LP450 participantsStarted Aug 2011

Alabaster, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +146 more locations

Multiple Dose Study Of PF-05231023 In Adult Subjects Who Have Poor Lipid Control With And Without Type 2 Diabetes Mellitus

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Find Trials by Condition in North Carolina

A Safety Study of TTP4000 in Subjects With Alzheimer's Disease

Study of Physiological and High Dose Estradiol in the Treatment of Hormone Receptor Positive Metastatic Breast Cancer

hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma

Determining the Barriers and Motivations to Clinical Trial Participation

The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) Study

Post-Partum Immunization With Live Attenuated Influenza Vaccine (LAIV) or Trivalent Influenza Vaccine (TIV) in Post-Partum Breast Feeding Women

Magnetic Seizure Therapy (MST) for Severe Mood Disorder

Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza

Study With TMX-101 in Patients With Carcinoma In Situ (CIS) Bladder Cancer

Prevention of GBS Colonization Via Immunity

Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia

Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis

A Study of TMC435 in Combination With PSI-7977 (GS7977) in Chronic Hepatitis C Genotype 1-Infected Prior Null Responders To Peginterferon/Ribavirin Therapy or HCV Treatment-Naive Patients

A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In US Adolescents and Adults

Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY

Ligation of the Intersphincteric Fistula Tract (LIFT) + Biodesign for Anal Fistula

A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer

Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Healthy Adults